UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 146

Sortiert nach

Subcortical gray matter atrophy is associated with cognitive deficit in multiple sclerosis but not in systemic lupus erythematosus patients

Lupus, 2018-04, Vol.27 (4), p.610-620

2018

Volltextzugriff (PDF)

Distinct regional brain atrophy pattern in multiple sclerosis and neuropsychiatric systemic lupus erythematosus patients

Lupus, 2018-09, Vol.27 (10), p.1624-1635

2018

Volltextzugriff (PDF)

Quality of life in stroke patients

Acta neurologica Scandinavica, 2003-05, Vol.107 (5), p.324-329

2003

Volltextzugriff (PDF)

Neurological paraneoplastic syndromes in lung cancer patients

Advances in experimental medicine and biology, 2013-01, Vol.756, p.333

2013

Volltextzugriff (PDF)

Pulsatility index in carotid arteries is increased in levothyroxine-treated Hashimoto disease

Hormone and metabolic research, 2015-07, Vol.47 (8), p.577

2015

Volltextzugriff (PDF)

Patient-reported quality of life in multiple sclerosis differs between cultures and countries: a cross-sectional Austrian–German–Polish study

Multiple sclerosis, 2011-04, Vol.17 (4), p.478-486

2011

Volltextzugriff (PDF)

Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome

European journal of medical research, 2009-12, Vol.14 Suppl 4 (Suppl 4), p.156-161

2009

Volltextzugriff (PDF)

Humoral Immune Response against Neural Antigens and Its Effects on Cognition in Lung Cancer Patients

Advances in Respiratory Cancerogenesis, 2016, Vol.911, p.59-66

2016

Volltextzugriff (PDF)

Substantia nigra hyperechogenicity in Polish patients with Parkinson's disease

Folia morphologica, 2014-08, Vol.73 (3), p.267-271

2014

Volltextzugriff (PDF)

FP58-FR-02 Plasma concentrations of ischemia-modified albumin in migraine patients

Journal of the neurological sciences, 2009, Vol.285, p.S149-S149

2009

Volltextzugriff (PDF)

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

The New England journal of medicine, 2011-10, Vol.365 (14), p.1293-1303

2011

Volltextzugriff (PDF)

TREATMENT OF ALCOHOLIC POLYNEUROPATHY WITH VITAMIN B COMPLEX: A RANDOMISED CONTROLLED TRIAL

Alcohol and alcoholism (Oxford), 2006-11, Vol.41 (6), p.636-642

2006

Volltextzugriff (PDF)

P2.083 Level of oxidative DNA damage and expression of apoptotic proteins in patients with Parkinson's disease treatment with L-dopa

Parkinsonism & related disorders, 2009, Vol.15, p.S111-S111

2009

Volltextzugriff (PDF)

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

The New England journal of medicine, 2010-02, Vol.362 (5), p.387-401

2010

Volltextzugriff (PDF)

FP25-TU-05 Serum VEGF concentration in patients with paraneoplastic neurological syndromes and ovarian tumors

Journal of the neurological sciences, 2009, Vol.285, p.S97-S97

2009

Volltextzugriff (PDF)

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis

The New England journal of medicine, 2008-10, Vol.359 (17), p.1786-1801

2008

Volltextzugriff (PDF)

Randomized Withdrawal Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension Responsive to Droxidopa

Hypertension (Dallas, Tex. 1979), 2015-01, Vol.65 (1), p.101-107

2015

Volltextzugriff (PDF)

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis

The New England journal of medicine, 2010-02, Vol.362 (5), p.416-426

2010

Volltextzugriff (PDF)

Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study

Neurology, 2016-03, Vol.86 (10), p.920

2016

Volltextzugriff (PDF)

Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke

Thrombosis and haemostasis, 2012-02, Vol.107 (2), p.346

2012

Volltextzugriff (PDF)

1.102 Homocysteine and asymmetric dimethylarginine (ADMA) in the plasma of patients with Parkinson's disease

Parkinsonism & related disorders, 2007, Vol.13, p.S34-S34

2007

Volltextzugriff (PDF)

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

Lancet neurology, 2012-05, Vol.11 (5), p.420-428

2012

Volltextzugriff (PDF)

Platelet activation and reactivity in the convalescent phase of ischaemic stroke

Thrombosis and haemostasis, 2010-03, Vol.103 (3), p.644

2010

Volltextzugriff (PDF)

Magnetic resonance imaging outcomes from a phase III trial of teriflunomide

Multiple sclerosis, 2013-09, Vol.19 (10), p.1310-1319

2013

Volltextzugriff (PDF)

Reactive leptin resistance and the profile of platelet activation in acute ischaemic stroke patients

Thrombosis and haemostasis, 2012-07, Vol.108 (1), p.107

2012

Volltextzugriff (PDF)

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(119)
Polnisch
(27)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Subcortical gray matter atrophy is associated with cognitive deficit in multiple sclerosis but not in systemic lupus erythematosus patients

Distinct regional brain atrophy pattern in multiple sclerosis and neuropsychiatric systemic lupus erythematosus patients

Quality of life in stroke patients

Neurological paraneoplastic syndromes in lung cancer patients

Pulsatility index in carotid arteries is increased in levothyroxine-treated Hashimoto disease

Patient-reported quality of life in multiple sclerosis differs between cultures and countries: a cross-sectional Austrian–German–Polish study

Onconeuronal and antineuronal antibodies in patients with neoplastic and non-neoplastic pulmonary pathologies and suspected for paraneoplastic neurological syndrome

Humoral Immune Response against Neural Antigens and Its Effects on Cognition in Lung Cancer Patients

Substantia nigra hyperechogenicity in Polish patients with Parkinson's disease

FP58-FR-02 Plasma concentrations of ischemia-modified albumin in migraine patients

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

TREATMENT OF ALCOHOLIC POLYNEUROPATHY WITH VITAMIN B COMPLEX: A RANDOMISED CONTROLLED TRIAL

P2.083 Level of oxidative DNA damage and expression of apoptotic proteins in patients with Parkinson's disease treatment with L-dopa

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

FP25-TU-05 Serum VEGF concentration in patients with paraneoplastic neurological syndromes and ovarian tumors

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis

Randomized Withdrawal Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension Responsive to Droxidopa

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis

Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study

Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke

1.102 Homocysteine and asymmetric dimethylarginine (ADMA) in the plasma of patients with Parkinson's disease

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

Platelet activation and reactivity in the convalescent phase of ischaemic stroke

Magnetic resonance imaging outcomes from a phase III trial of teriflunomide

Reactive leptin resistance and the profile of platelet activation in acute ischaemic stroke patients

Suchergebnisse filtern